Literature DB >> 16014718

Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury.

T Bucky Jones1, Ronald P Hart, Phillip G Popovich.   

Abstract

The intraspinal cues that orchestrate T-cell migration and activation after spinal contusion injury were characterized using B10.PL (wild-type) and transgenic (Tg) mice with a T-cell repertoire biased toward recognition of myelin basic protein (MBP). Previously, we showed that these strains exhibit distinct anatomical and behavioral phenotypes. In Tg mice, MBP-reactive T-cells are activated by spinal cord injury (SCI), causing more severe axonal injury, demyelination, and functional impairment than is found in non-Tg wild-type mice (B10.PL). Conversely, despite a robust SCI-induced T-cell response in B10.PL mice, no overt T-cell-mediated pathology was evident. Here, we show that chronic intraspinal T-cell accumulation in B10.PL and Tg mice is associated with a dramatic and sustained increase in CXCL10/IP-10 and CCL5/RANTES mRNA expression. However, in Tg mice, chemokine mRNA were enhanced 2- to 17-fold higher than in B10.PL mice and were associated with accelerated intraspinal T-cell influx and enhanced CNS macrophage activation throughout the spinal cord. These data suggest common molecular pathways for initiating T-cell responses after SCI in mice; however, if T-cell reactions are biased against MBP, molecular and cellular determinants of neuroinflammation are magnified in parallel with exacerbation of neuropathology and functional impairment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014718      PMCID: PMC1578736          DOI: 10.1523/JNEUROSCI.0305-05.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

Review 1.  The role of chemokine receptors in primary, effector, and memory immune responses.

Authors:  F Sallusto; C R Mackay; A Lanzavecchia
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Traumatic spinal cord injury produced by controlled contusion in mouse.

Authors:  L B Jakeman; Z Guan; P Wei; R Ponnappan; R Dzwonczyk; P G Popovich; B T Stokes
Journal:  J Neurotrauma       Date:  2000-04       Impact factor: 5.269

3.  Localization of transforming growth factor-beta1 and receptor mRNA after experimental spinal cord injury.

Authors:  D M McTigue; P G Popovich; T E Morgan; B T Stokes
Journal:  Exp Neurol       Date:  2000-05       Impact factor: 5.330

4.  RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation.

Authors:  V Appay; P R Dunbar; V Cerundolo; A McMichael; L Czaplewski; S Rowland-Jones
Journal:  Int Immunol       Date:  2000-08       Impact factor: 4.823

5.  Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells.

Authors:  H Hammarberg; O Lidman; C Lundberg; S Y Eltayeb; A W Gielen; S Muhallab; A Svenningsson; H Lindå; P H van Der Meide; S Cullheim; T Olsson; F Piehl
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

6.  The insulin-like growth factor-I receptor is regulated by CD28 and protects activated T cells from apoptosis.

Authors:  P T Walsh; R O'Connor
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

7.  Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen.

Authors:  L A Tylaska; L Boring; W Weng; R Aiello; I F Charo; B J Rollins; R P Gladue
Journal:  Cytokine       Date:  2002-05-21       Impact factor: 3.861

8.  Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord.

Authors:  C Lagord; M Berry; A Logan
Journal:  Mol Cell Neurosci       Date:  2002-05       Impact factor: 4.314

9.  Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion.

Authors:  Manhong Ma; Tao Wei; Landin Boring; Israel F Charo; Richard M Ransohoff; Lyn B Jakeman
Journal:  J Neurosci Res       Date:  2002-06-15       Impact factor: 4.164

10.  Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.

Authors:  L Izikson; R S Klein; I F Charo; H L Weiner; A D Luster
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  34 in total

1.  The PPAR alpha agonist gemfibrozil is an ineffective treatment for spinal cord injured mice.

Authors:  Akshata Almad; A Todd Lash; Ping Wei; Amy E Lovett-Racke; Dana M McTigue
Journal:  Exp Neurol       Date:  2011-09-21       Impact factor: 5.330

2.  Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury.

Authors:  Kristina A Kigerl; Violeta M McGaughy; Phillip G Popovich
Journal:  J Comp Neurol       Date:  2006-02-01       Impact factor: 3.215

Review 3.  Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury.

Authors:  Dustin J Donnelly; Phillip G Popovich
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

Review 4.  Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.

Authors:  Stefka Gyoneva; Richard M Ransohoff
Journal:  Trends Pharmacol Sci       Date:  2015-05-13       Impact factor: 14.819

5.  Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke.

Authors:  Christine Römer; Odilo Engel; Katarzyna Winek; Sonja Hochmeister; Tian Zhang; Georg Royl; Juliane Klehmet; Ulrich Dirnagl; Christian Meisel; Andreas Meisel
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

6.  Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury.

Authors:  Yaniv Ziv; Hila Avidan; Stefano Pluchino; Gianvito Martino; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-22       Impact factor: 11.205

7.  Inducible protein-10, a potential driver of neurally controlled interleukin-10 and morbidity in human blunt trauma.

Authors:  Akram M Zaaqoq; Rami Namas; Khalid Almahmoud; Nabil Azhar; Qi Mi; Ruben Zamora; David M Brienza; Timothy R Billiar; Yoram Vodovotz
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

8.  Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.

Authors:  Kevin D Beck; Hal X Nguyen; Manuel D Galvan; Desirée L Salazar; Trent M Woodruff; Aileen J Anderson
Journal:  Brain       Date:  2010-01-19       Impact factor: 13.501

Review 9.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

10.  Microglial responses around intrinsic CNS neurons are correlated with axonal regeneration.

Authors:  Bahman N Shokouhi; Bernadette Z Y Wong; Samir Siddiqui; A Robert Lieberman; Gregor Campbell; Koujiro Tohyama; Patrick N Anderson
Journal:  BMC Neurosci       Date:  2010-02-05       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.